Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Nov;100(5):1289-95.
doi: 10.1016/j.fertnstert.2013.07.1966. Epub 2013 Aug 15.

Thin endometrium in donor oocyte recipients: enigma or obstacle for implantation?

Affiliations
Free article
Comparative Study

Thin endometrium in donor oocyte recipients: enigma or obstacle for implantation?

Lena Dain et al. Fertil Steril. 2013 Nov.
Free article

Abstract

Objective: To evaluate the combined effect of endometrial thickness and anatomic uterine factors on clinical outcome in oocyte donation recipients.

Design: Retrospective analysis of oocyte donation cycles conducted between 2005 and 2010.

Setting: Two private IVF centers.

Patient(s): A total of 737 donor oocyte cycles.

Intervention(s): None.

Main outcome measure(s): Clinical pregnancy and live birth rates.

Result(s): No statistically significant difference was found in clinical pregnancy rates and live birth rates in cycles with endometrial thickness <6 mm compared with those with endometrial thickness >10 mm. However, a relatively high rate of live births was found within a medium range of endometrial thickness (8.2-10 mm). All intrauterine adhesion cases occurred in cycles with thinner endometrium.

Conclusion(s): No statistically significant difference was found in clinical pregnancy rates and live birth rates in cycles with endometrial thickness <6 mm compared with those with thickness >6 mm. A relatively high rate of live births was found within a medium range of endometrial thickness (9.1-10 mm).

Keywords: Endometrial thickness; estrogen replacement therapy; oocyte donation; uterine factors.

PubMed Disclaimer

MeSH terms

LinkOut - more resources